RN7SK pseudogene 66 (RN7SKP66)

RN7SK pseudogene 66 (RN7SKP66) is a predicted or annotated pseudogene related to the active RN7SK small nuclear RNA (7SK snRNA), which itself is a well-characterized noncoding RNA involved in the regulation of RNA polymerase II transcription elongation via sequestration of P-TEFb[1][2][3]. However, as a pseudogene, RN7SKP66 does not encode an active RNA product and does not appear in major gene/protein databases as a functional molecule. There is no reported evidence for transcriptional activity, biological function, disease association, or pharmacological modulation of RN7SKP66, differentiating it from its parent gene RN7SK, which is biologically important[1][2]. RN7SKP66 is not a therapeutic target and does not fall under known molecular target classes such as "receptor," "enzyme," or "transporter." No ligands, drugs, or clinical relevance is associated with this sequence. The entry may be included in genomic databases for reference as a pseudogene or as part of annotation efforts, but it is not a target for therapy or biomarker use in any known context[2].

Other names

RNA, 7SK small nuclear pseudogene 66RN7SKP66RN7SKP66 pseudogene7SK pseudogene 66